Dr. Amanda Chelednik, MD

Dr. Chelednik practices at Cox Medical Center South in Springfield, Missouri, part of Lester E. Cox Medical Centers.

Dr. Chelednik's NPI, 1710337746, was assigned on June 21, 2016. Dr. Chelednik graduated from University of Florida College of Medicine in 2016. Dr. Chelednik holds Missouri license 2016020829.

Dr. Chelednik's primary practice is Cox Medical Center South, at 3801 South National Avenue, Springfield, MO 65807 in Greene County. The practice phone is (417) 269-6000.

Dr. Chelednik's primary practice is Cox Medical Center South in Springfield, Missouri, part of Lester E. Cox Medical Centers. Dr. Chelednik is also affiliated with Cox Medical Center Branson. The medical group on file is Ferrell-Duncan Clinic. Dmand AI also links Dr. Chelednik to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chelednik practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Chelednik's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Chelednik is licensed in Missouri.

CMS data shows 209 Medicare services from Dr. Chelednik across 5 procedure codes in 2024, for 148 Medicare patients. Medicare paid $17,819 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 148 Medicare patients who saw Dr. Chelednik in 2024. The largest group is 75 to 84, with 58 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chelednik's median patient age at 65, with 53% women.

In 2024, Dr. Chelednik wrote 67 Medicare Part D claims for 38 patients. 99% of them were for generic drugs. CMS names the drug for 36 of them, across 2 drugs with 11 or more claims each, at $112 in total drug cost. In 2023, CMS named 24 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Chelednik for performance year 2024, reported as part of a group. Dr. Chelednik accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 75 general payments to Dr. Chelednik from 16 drug and device companies from 2016 to 2025. Education make up the largest share, 57% of the total. Intuitive Surgical, Inc. paid the most, $15,204.

Dr. Chelednik graduated from University of Florida College of Medicine in 2016.